Skip to main content
. Author manuscript; available in PMC: 2018 Mar 1.
Published in final edited form as: J Urol. 2016 Sep 25;197(3 Pt 1):753–758. doi: 10.1016/j.juro.2016.09.080

Table 1.

Characteristics of the participants with and without NP

Characteristics All (n=284) With NP (n=186) Without NP (n=98) p-value

Age, yr [sd] 72.9 [7.9] 73 [7.9] 72 [7.8] .12

BMI, [sd] 29.8 [6.5] 30.3 [6.6] 29.9 [6.4] .17

Smoking, % (n)-
 none 57 (161) 58 (108) 54 (53) .26
 Past 38 (107) 34 (64) 43 (43)
 Current 4 (12) 5 (10) 2 (2)

Alcohol, % (n) 4 (12) 6 (11) 6 (6) .91

Edema, % (n) 32 (90) 33 (61) 29 (29) .46

Albumin, [sd] 4.2 [0.3] 4.2 [0.3] 4.2 [0.3] .43

Creatinine, [sd] 0.9 [0.2] 0.9 [0.2] 0.9 [0.2] .85

Medication use, % (n)

ACE/ARB 31 (87) 29 (54) 34 (33) .39

Diuretic 28 (78) 27 (50) 29 (28) .72

CCB 14 (39) 16 (30) 9 (9) .11

Anti-cholinergic 13 (38) 11 (21) 17(17) .14

Anti-depressant 17 (48) 18 (33) 15 (15) .61

NSAIDS 24 (67) 25 (46) 21 (21) .49

Comorbidities, % (n)

Cardiovascular 36 (104) 39 (72) 32 (32) .11

Neurological 13 (37) 14 (26) 11 (11) .14

Respiratory 26 (74) 29 (54) 20 (20) .12

Musculoskeletal 54 (154) 62 (116) 38 (38) .07

Diabetes 16 (45) 17 (32) 13 (13) .42

Psychiatric 20 (56) 23 (43) 13 (13) .20

Cancer 11 (34) 6 (11) 23 (23) .10

Note: BMI= body mass index, CCB= calcium channel blockers, NSAIDS= non-steroidal anti-inflammatory drugs, SD= standard deviation. Comorbidities included the following: cardiovascular disease (hypertension, atrial fibrillation, congestive heart failure, or heart attack), neurologic (peripheral neuropathy, Parkinson’s disease, stroke), respiratory (COPD, asthma, chronic bronchitis), musculoskeletal conditions (arthritis, osteoporosis, or joint replacement), diabetes, psychiatric (depression, anxiety) or cancer.